Special Interest Group Satellites (SIGs)

Member led Special Interest Group Satellites are programmed by members for members.  With the support of SLB, these sessions will add to the value of 2019 attendance and provide extended learning opportunities. Consider hosting your own SIG and contact us for availability. There is a $20 USD fee for attending the SIGs. Sign-up and secure your spot during the main registration process. Main conference registration is required to join for the SIGs. Review all 8 options below. There is one full day option, 3 morning sessions and 4 afternoon sessions.

November 15, 2019

9:00 am – 5:00 pm

Alcohol & Tissue-Specific Immunity (AIRIG)
Chairs:Elizabeth J. Kovacs, University of Colorado, Denver & Mashkoor A. Choudhry, Loyola University, Chicago

  • Majid Afshar, MD, MS, Loyola University Chicago, Blood and urine biomarkers for identifying alcohol misuse in trauma patients
  • Leon G. Coleman, Jr., MD, PhD, University of North Carolina, Chapel Hill, Neuroimmune Mechanisms of Alcoholic Neurodegeneration and Negative Affect
  • Rebecca McCullough, PhD, University of Colorado Denver, Targeting the resolution of inflammation with a novel cell-based therapy in Alcoholic Liver Disease.
  • Vasilis Vasiliou, PhD, Yale University, Biomarkers and Novel Pathways Involved in the Development of Alcoholic Liver Disease
  • H. Joe Wang, PhD, NIAAA, Funding and training opportunities

9:00 am – 12:00 pm

Immunomodulatory Cell Death

Chair: Ben A. Croker, Ph.D.

  • Ben A. Croker, Boston Children’s Hospital, Harvard Medical School, Effector Functions of Neutrophil Necroptosis
  • Andrew Oberst, University of Washington, Necroptosis Minus Cell Death Equals Antiviral Immunity in the Brain
  •  Kristopher Sarosiek, Harvard T.H. Chan School of Public Health, Enhancing Anti-cancer Immune Responses by Modulating Tumor Cell Death
  • Kate Schroder, The University of Queensland, New Insights into Non-canonical Inflammasome Signaling and Functions in Host Defense

OR

Progress in CRISPR-Cas Biology and Gene Editing
Chair: Min Wu, University of North Dakota

  • Zhiwei Huang, Harbin Institute of Technology, How the Unique Structures of CRISPR-Cas Facilitate the Gene Editing
  • Samira Kiani, Arizona State University, How Many Applications Can the CRISPR Biotechnology Bring?
  • Eugene Koonin, NIH, The Expanding CRISPR Universe
  • Ailong Ke, Cornell, Structure and Function for CRISPR-Cas Research: The Recent Highlights
  • Min Wu, University of North Dakota, Can We Find or Reinvent the Best CRISPR-Cas for Gene Editing?

OR

Resolution of Inflammation
Chairs: Charles N Serhan and Stephania Libreros, Harvard Medical School and Brigham and Women’s Hospital

  • Charles N Serhan, Harvard Medical School and Brigham and Women’s Hospital, Novel Mediators of Inflammation Resolution and Tissue Regeneration
  • Matthew Spite, Harvard Medical School and Brigham and Women’s Hospital, Lipid Mediators at the Interface of Resolution of Inflammation and Tissue Repair
  • Mark Tepper, Corbus Pharmaceutics, CB1 agonist activates Pro-resolving Lipid Mediators in Humans
  • Gabrielle Fredman, Albany Medical College, Resolvin D1 Enhances Necroptotic Cell Clearance
  • Danielle Irimia, Harvard Medical School and Massachusetts General Hospital, Lipid Mediators of Neutrophil Swarming

1:00 pm – 4:00 pm

Immune Regulation, Autoimmunity and Infection
Chairs: Rachel Caspi, PhD & WanJun Chen, MD

  • Philip Murphy, NIAID, NIH, Treatment and Cure Strategies for WHIM Syndrome Immunodeficiency
  • Munir Akkaya, NIAID, NIH, How TLR9 Signaling Shapes the Survival, Differentiation and the Metabolism of B Cells
  • Mate Tolnay, CDER, FDA, Human FCRL3 Binds Secretory IgA, an Essential Component of Mucosal Immunity, and Restrains Regulatory T Cell Activity
  • Daniela Verthelyi, FDA, Modeling Neurotropic Viruses in Immunocompetent Mice: What Have We Learned So Far
  • Rachel Caspi, NEI, NIH, Th17 Effector Regulation in Ocular Inflammatory Disease
  • Billur Akkaya, NIAID, NIH, Tregs Orchestrate Antigen Specific Suppression via Stripping Cognate Peptide-MHCII from the DC Surface
  • WanJun Chen, NIDCR, NIH, D-mannose induces regulatory T cells and suppresses autoimmunity and inflammation

OR

Advanced Imaging Approaches to Visualize Immune Cell Behavior
Chairs Margarida Barroso & Sergio Catz

Sponsored by the Histochemical Society

  • Sergio Catz, The Scripps Research Institute Application of Total Internal Reflection Fluorescence and Super Resolution Microscopy to the Study of Neutrophil Function
  • Margarida Barroso, Albany Medical College Fluorescence Lifetime FRET Based Approaches to Visualize Immune Cell Function
  • Klaus Ley, La Jolla Institute for Immunology, TITLE TBD
  • Mauricio Terebiznik, University of Toronto, TITLE TBD

OR

Impact of Aging on Tissue Resident Immune Cells
Chairs: Rebecca Fuldner, NIA, NIH

  • David Koelle, University of Washington, Skin-resident T Cell Responses to VZV Infection and Vaccination
  • Susan Swain, University of Massachusetts Medical School, Tissue Resident Memory Cells and Aging
  • Deep Dixit, Yale University, Adipose Tissue Resident Leukocytes in Aging and Inflammation
  • Joanne Turner, Texas Biomedical Research Institute, Exploring the Impact of Inflammaging on Immune Function During M. tb Infection

OR

Global Science: Around the World Advancements in Immunology Research
Chair: Luis Montaner, Wistar, JLB Editor-in-Chief

Program TBA